Written question asked by Paula Barker (Labour) on Wednesday, 12 February 2025, in the House of Commons. It was due for an answer on Monday, 24 February 2025. It was answered by Feryal Clark (Labour) on Friday, 28 February 2025 on behalf of the Department for Science, Innovation and Technology.
Life Sciences: Merseyside
- Question
-
To ask the Secretary of State for Science, Innovation and Technology, whether funding made available for the AstraZeneca vaccine project in Liverpool will remain available for other life science projects in the Liverpool City region.
- Answer
-
The Government supports the vibrant life sciences sector, which contributes £108 billion to the economy and 300,000 jobs nationwide. A new Life Sciences Sector Plan, part of the upcoming Industrial Strategy, is due to be published in late Spring. This will set out a comprehensive plan of how the Government intends to drive growth in the sector. In addition, the Life Sciences Innovative Manufacturing Fund will allocate up to £520 million to deliver economic growth and build health resilience, and is available UK-wide, including to projects in the Liverpool City region
Secondary information
- Type
- Written question
- Reference
- 31137
- Session
- 2024-26
- Transferred
- Yes
- Subjects
- Finance Merseyside Production Vaccination AstraZeneca Life sciences
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 17:49:25 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/31137
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/31137
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/31137